FRBN Stock Overview
Forbion European Acquisition Corp. does not have significant operations.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Forbion European Acquisition Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$21.70 |
| 52 Week High | US$47.17 |
| 52 Week Low | US$9.25 |
| Beta | 0 |
| 11 Month Change | 99.40% |
| 3 Month Change | 101.25% |
| 1 Year Change | 113.74% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 120.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| FRBN | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 21.5% | -0.1% | 0.7% |
| 1Y | 113.7% | 29.0% | 23.3% |
Return vs Industry: FRBN exceeded the US Capital Markets industry which returned 8% over the past year.
Return vs Market: FRBN exceeded the US Market which returned 14.1% over the past year.
Price Volatility
| FRBN volatility | |
|---|---|
| FRBN Average Weekly Movement | 34.8% |
| Capital Markets Industry Average Movement | 3.5% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: FRBN's share price has been volatile over the past 3 months.
Volatility Over Time: FRBN's weekly volatility has increased from 20% to 35% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Jasper Bos | forbion.com/en/feac/ |
Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe.
Forbion European Acquisition Corp. Fundamentals Summary
| FRBN fundamental statistics | |
|---|---|
| Market cap | US$343.05m |
| Earnings (TTM) | -US$3.23m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-106.3x
P/E RatioIs FRBN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FRBN income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$3.23m |
| Earnings | -US$3.23m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -27.4% |
How did FRBN perform over the long term?
See historical performance and comparison